Latest news
Loading news…
Paratek Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Boston, Massachusetts, United States Founded 1996 251-500 employees For Profit
Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies.
Paratek Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Paratek Pharmaceuticals was acquired by Novo Holdings in 2023 for $462M.
Total Funding
$264.1M
Funding Rounds
5
Last Funding
Acquisitions
3
Monthly Visits
Contacts
304
Ticker
PRTK
NASDAQ
Patents
41
42 trademarks
About Paratek Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- PRTK
- Exchange
- NASDAQ
- IPO date
- Oct 30, 2014
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 20
- Active products
- 26
- Patents granted
- 41
- Trademarks
- 42
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $2.76M
Company Info
- Founded
- 1996
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 1
- News articles
- 108
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Oct 30, 2014
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- -2.8
Paratek Pharmaceuticals Funding Rounds
5 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 5Show
Page 1 / 1
Paratek Pharmaceuticals Acquisitions
3 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Radius Health | — | 2026-03-19 | Paratek Pharmaceuticals | BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalWomen's | United States |
| OptiNose | $330M | 2025-03-19 | Paratek Pharmaceuticals | BiotechnologyMedical DevicePharmaceutical | Norway |
| Transcept Pharmaceuticals | — | 2014-10-30 | Paratek Pharmaceuticals | BiotechnologyNeurosciencePharmaceuticalTherapeutics | United States |
1–3 of 3Show
Page 1 / 1
Paratek Pharmaceuticals Key People
Senior Director U.S. Sales
304
professional contacts at Paratek Pharmaceuticals
Contact execs at Paratek Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Paratek Pharmaceuticals
Loading news…
FAQs about Paratek Pharmaceuticals
People who checked this page also checked these
Sectors Paratek Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.